FDA Inspection 644628 — Nagrani Mark, Md
The FDA completed an inspection of Nagrani Mark, Md on Feb 4, 2010 in New Smyrna Beach, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 4, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- New Smyrna Beach, FL (United States)
Additional Details
Clinical Investigator (CI)